Meanwhile, treatment with erianin could arrest the cell cycle at the G2/M phase by regulating the expression of p53, p27, and p21 in cancers, including gastric cancer, colon cancer, and osteosarcoma. This evidence concerns the gene TP53 and osteosarcoma.